logo
logo

Exo® Acquires Medo Ai To Make Medical Imaging As Easy As Snapping A Smartphone Photo

Jul 26, 2022•about 3 years ago

Acquiring Company

Exo

Acquired Company

Medo AI

Redwood CitySportsCommerce And Shopping

Description

Exo (pronounced “echo”), a pioneering health information and medical devices company, today announced that it is acquiring Medo, a Canadian developer of artificial intelligence (AI) technology, to make ultrasound imaging faster and simpler to use. By integrating Medo’s proprietary Sweep AITM technology into its ultrasound platform, Exo will make ultrasound imaging more accessible to a wider range of caregivers.

Company Information

Company

Exo

Location

Redwood City, California, United States

About

The new funding gives the Redwood City, California-based company over $320 million in total investments since the company was founded in 2015, Exo CEO Sandeep Akkaraju told TechCrunch.

Related People

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed